Winter Charles M. 4
4 · Janux Therapeutics, Inc. · Filed Jan 2, 2026
Insider Transaction Report
Form 4
Winter Charles M.
Chief Technical Officer
Transactions
- Sale
Common Stock
2026-01-02$13.73/sh−2,401$32,966→ 77,721 total - Award
Common Stock
2026-01-02+28,600→ 106,321 total - Award
Stock option (right to buy)
2026-01-02+100,100→ 100,100 totalExercise: $13.65Exp: 2036-01-01→ Common Stock (100,100 underlying)
Footnotes (4)
- [F1]The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F2]Includes 2,834 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on May 15, 2025.
- [F3]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.
- [F4]25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.